Laboratoires Pierre Fabre SA - Strategic SWOT Analysis Review

December 2021 | 33 pages | ID: LB1C502149CEN
GlobalData

Abstracts

Laboratoires Pierre Fabre SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Laboratoires Pierre Fabre SA (Pierre Fabre), a subsidiary of Pierre Fabre Foundation that develops products and solutions including health and beauty. Its comprehensive product portfolio comprises of a range of complementary products, from prescribed drugs to dermo-cosmetics, including over-the-counter drugs and natural health products. The company’s products address the full spectrum of health care needs from pathologies such as cancer or atopical dermatitis to rare diseases including pediatric hemangioma, family hygiene to skin, hair and scalp care; and from day-to-day illnesses. Pierre Fabre sells and markets its products under various brands, including Derma, Galenic Klorane, Avene, Ducray and Rene Furterer, among others. Pierre Fabre is headquartered in Ile-de-France, France.

Laboratoires Pierre Fabre SA Key Recent Developments

Oct 07,2021: Talem Therapeutics announces multi-target antibody discovery research collaboration with Pierre Fabre
Jul 09,2021: The Pierre Fabre Group Has Appointed Dr Francesco Hofmann
Jul 09,2021: Francesco Hofmann is appointed head of R&D at Pierre Fabre Medical Care

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Laboratoires Pierre Fabre SA - Key Facts
Laboratoires Pierre Fabre SA - Key Employees
Laboratoires Pierre Fabre SA - Key Employee Biographies
Laboratoires Pierre Fabre SA - Major Products and Services
Laboratoires Pierre Fabre SA - History
Laboratoires Pierre Fabre SA - Company Statement
Laboratoires Pierre Fabre SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate

SECTION 2 – COMPANY ANALYSIS

Company Overview
Laboratoires Pierre Fabre SA - Business Description
Business Segment: Dermo-Cosmetics
Overview
Performance
Business Segment: Medical Care
Overview
Performance
Business Segment: Other Activities
Performance
Geographical Segment: France
Performance
Geographical Segment: International
Performance
R&D Overview
Laboratoires Pierre Fabre SA - SWOT Analysis
SWOT Analysis - Overview
Laboratoires Pierre Fabre SA - Strengths
Laboratoires Pierre Fabre SA - Weaknesses
Laboratoires Pierre Fabre SA - Opportunities
Laboratoires Pierre Fabre SA - Threats
Laboratoires Pierre Fabre SA - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Laboratoires Pierre Fabre SA, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Oct 07, 2021: Talem Therapeutics announces multi-target antibody discovery research collaboration with Pierre Fabre
Jul 09, 2021: The Pierre Fabre Group Has Appointed Dr Francesco Hofmann
Jul 09, 2021: Francesco Hofmann is appointed head of R&D at Pierre Fabre Medical Care

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Laboratoires Pierre Fabre SA, Key Facts
Laboratoires Pierre Fabre SA, Key Employees
Laboratoires Pierre Fabre SA, Key Employee Biographies
Laboratoires Pierre Fabre SA, Major Products and Services
Laboratoires Pierre Fabre SA, History
Laboratoires Pierre Fabre SA, Other Locations
Laboratoires Pierre Fabre SA, Subsidiaries
Laboratoires Pierre Fabre SA, Affiliate
Laboratoires Pierre Fabre SA, Key Competitors
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Laboratoires Pierre Fabre SA, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Laboratoires Pierre Fabre SA, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021